Skip to content

5q31 3 Deletion Syndrome Cn381296

Published: July 22, 2026Updated: August 20, 2026

A genetic condition from missing genetic material in a specific chromosome 5 region, potentially causing developmental delays, distinctive features, and other health issues. Care is supportive and personalized.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defects

Structural heart abnormalities including septal defects, valve malformations, or other cardiac anomalies present at birth.

Seek immediate care if symptoms of heart failure develop such as rapid breathing, poor feeding, or cyanosis.

!

Seizures

Epileptic episodes that may vary in type from focal to generalized seizures.

Seek emergency care for any seizure lasting more than 5 minutes or if multiple seizures occur in 24 hours.

Developmental delay

(neurologic)

Delayed attainment of motor milestones such as sitting, walking, and crawling compared to typical developmental timelines.

Frequency: 80-90% of patients

Dysmorphic facial features

(constitutional)

Distinctive facial characteristics including broad forehead, abnormal ear placement, and distinctive nose or mouth shape.

Frequency: 85-95% of patients

Intellectual disability

(neurologic)

Variable degrees of cognitive impairment affecting learning, problem-solving, and adaptive functioning.

Frequency: 75-85% of patients

Growth retardation

(constitutional)

Slowed physical growth resulting in short stature and below-average weight gain over time.

Frequency: 60-70% of patients

Hypotonia

(neurologic)

Reduced muscle tone presenting as floppiness in infancy, affecting movement and motor skill development.

Frequency: 55-65% of patients

Speech delay

(neurologic)

Delayed onset of speech and language development, with expressive language more affected than receptive language.

Frequency: 65-75% of patients

Feeding difficulties

(gastrointestinal)

Problems with sucking, swallowing, or transitioning to solid foods, often associated with oral motor dysfunction.

Frequency: 25-35% of patients

Renal abnormalities

(genitourinary)

Kidney malformations such as horseshoe kidney, renal hypoplasia, or urinary tract anomalies.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Neurodevelopmental Assessment

Comprehensive and recurring neurodevelopmental evaluations to track cognitive progress, identify emerging challenges, and guide appropriate intervention strategies.

monitoring
3

Antiepileptic Treatment

Individualized anticonvulsant medication regimen for seizure control, with regular electroencephalogram monitoring and medication level assessments to optimize therapy.

medication

Additional treatment options

Gross Motor Intervention

Structured physical therapy program addressing motor coordination difficulties, balance training, and strengthening exercises to maximize functional mobility.

physical_therapy

Behavioral and Cognitive Therapy

Applied behavior analysis and cognitive behavioral interventions to address behavioral challenges, improve social skills, and manage associated neuropsychiatric features.

psychological

Structured Daily Routine

Implementation of consistent daily schedules, environmental modifications, and sensory accommodations to reduce anxiety and support optimal functioning.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 5q31 3 Deletion Syndrome Cn381296?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wat MJ, et al. Clinical spectrum and molecular characterization of 5q31.3 microdeletion syndrome. American Journal of Medical Genetics Part A. 2012.

review2012
2

Cappuccio G, et al. 5q31.3 microdeletion syndrome: description of a case and review of the literature. Molecular Cytogenetics. 2014.

review2014
3

GeneReviews: 5q31.3 Microdeletion Syndrome. Adam MP, et al., editors. University of Washington, Seattle.

textbook2020View source →
4

Miller DT, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics. 2010.

review2010
5

American College of Medical Genetics and Genomics. Clinical genetics and genomic testing guidelines. Genetics in Medicine. 2013-2021.

position_statement2021
6

Orphanet: 5q31.3 microdeletion syndrome. Orphanet Rare Disease Registry.

7

Ladda R, et al. Chromosome 5q deletion syndromes: an overview of clinical features and genetic counseling. Journal of Genetic Counseling. 2019.

review2019
8

NCBI Genetics Home Reference: 5q31.3 microdeletion syndrome. National Library of Medicine.

textbook2021View source →
9

Rosenfeld JA, et al. Developmental outcomes in 5q31.3 microdeletion syndrome: a report of 12 new cases. American Journal of Medical Genetics Part A. 2013.

review2013
10

International Society of Psychiatric Genetics. Consensus guidelines for genetic testing in neurodevelopmental disorders. World Psychiatry. 2019.

consensus2019

Medication Comparisons

Compare medications used to treat 5q31 3 Deletion Syndrome Cn381296. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy